ITGAV Regulation of LGALS3BP-JUNB Axis Facilitates the Cell-to-Cell Adhesion and Invasiveness of Hepatic Cancer Cells

The LGALS3BP-JUNB axis regulates ITGAV expression and contributes to HCC progression. Targeting ITGAV, with LGALS3BP as a potential biomarker, and the combined inhibition of both LGALS3BP and ITGAV may represent a promising therapeutic strategy for HCC.